These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1217 related articles for article (PubMed ID: 10598751)

  • 41. The biochemistry of drug metabolism--an introduction: part 4. reactions of conjugation and their enzymes.
    Testa B; Krämer SD
    Chem Biodivers; 2008 Nov; 5(11):2171-336. PubMed ID: 19035562
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Different role of biotransformation in the elimination of some important pharmaceuticals and industrial xenobiotics.
    Gut I
    Arch Toxicol Suppl; 1980; 4():350-4. PubMed ID: 6933935
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Metabolic activation in drug-induced liver injury.
    Leung L; Kalgutkar AS; Obach RS
    Drug Metab Rev; 2012 Feb; 44(1):18-33. PubMed ID: 21939431
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Detecting reactive drug metabolites for reducing the potential for drug toxicity.
    Grillo MP
    Expert Opin Drug Metab Toxicol; 2015; 11(8):1281-302. PubMed ID: 26005795
    [TBL] [Abstract][Full Text] [Related]  

  • 45. A decade of drug metabolite safety testing: industry and regulatory shared learning.
    Luffer-Atlas D; Atrakchi A
    Expert Opin Drug Metab Toxicol; 2017 Sep; 13(9):897-900. PubMed ID: 28797172
    [No Abstract]   [Full Text] [Related]  

  • 46. Metabolic transformation of clinically used drugs to epoxides: new perspectives in drug-drug interactions.
    Oesch F
    Biochem Pharmacol; 1976 Sep; 25(17):1935-7. PubMed ID: 985529
    [No Abstract]   [Full Text] [Related]  

  • 47. Managing the liabilities arising from structural alerts: a safe philosophy for medicinal chemists.
    Edwards PJ; Sturino C
    Curr Med Chem; 2011; 18(20):3116-35. PubMed ID: 21651480
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Editorial. Bioactivation of drugs: enzymes, reactive metabolites and adverse reactions.
    Orhan H
    Curr Med Chem; 2015; 22(4):406-7. PubMed ID: 25515506
    [No Abstract]   [Full Text] [Related]  

  • 49. The biochemistry of drug metabolism--an introduction: part 5. Metabolism and bioactivity.
    Testa B; Krämer SD
    Chem Biodivers; 2009 May; 6(5):591-684. PubMed ID: 19479846
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Drug metabolites in safety testing.
    Hastings KL; El-Hage J; Jacobs A; Leighton J; Morse D; Osterberg RE
    Toxicol Appl Pharmacol; 2003 Jul; 190(1):91-2;author reply 93-4. PubMed ID: 12831788
    [No Abstract]   [Full Text] [Related]  

  • 51. Practical approaches to resolving reactive metabolite liabilities in early discovery.
    Dalvie D; Kalgutkar AS; Chen W
    Drug Metab Rev; 2015 Feb; 47(1):56-70. PubMed ID: 25410913
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Toxicology Strategies for Drug Discovery - Present and Future: Introduction.
    Humphreys WG; Will Y; Guengerich FP
    Chem Res Toxicol; 2016 Apr; 29(4):437. PubMed ID: 27087588
    [No Abstract]   [Full Text] [Related]  

  • 53. Chemical transformation of xenobiotics by the human gut microbiota.
    Koppel N; Maini Rekdal V; Balskus EP
    Science; 2017 Jun; 356(6344):. PubMed ID: 28642381
    [TBL] [Abstract][Full Text] [Related]  

  • 54. On the role of the peroxisome in the metabolism of drugs and xenobiotics.
    Masters CJ
    Biochem Pharmacol; 1998 Sep; 56(6):667-73. PubMed ID: 9751070
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Renal UDP-glucuronosyltransferases and the glucuronidation of xenobiotics and endogenous mediators.
    Knights KM; Miners JO
    Drug Metab Rev; 2010 Feb; 42(1):63-73. PubMed ID: 19780654
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Metabolic activation and drug toxicity.
    Nelson SD
    J Med Chem; 1982 Jul; 25(7):753-65. PubMed ID: 7050382
    [No Abstract]   [Full Text] [Related]  

  • 57. Metabolic profiling as a tool for understanding mechanisms of toxicity.
    Clarke CJ; Haselden JN
    Toxicol Pathol; 2008 Jan; 36(1):140-7. PubMed ID: 18337232
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Biomarkers, metabonomics, and drug development: can inborn errors of metabolism help in understanding drug toxicity?
    Vangala S; Tonelli A
    AAPS J; 2007 Jul; 9(3):E284-97. PubMed ID: 17915830
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Metabonomics: systems biology in pharmaceutical research and development.
    Lindon JC; Holmes E; Nicholson JK
    Curr Opin Mol Ther; 2004 Jun; 6(3):265-72. PubMed ID: 15264428
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Pattern recognition and biomarker validation using quantitative 1H-NMR-based metabolomics.
    Serkova NJ; Niemann CU
    Expert Rev Mol Diagn; 2006 Sep; 6(5):717-31. PubMed ID: 17009906
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 61.